Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
J Nutr Biochem ; 54: 48-56, 2018 04.
Article in English | MEDLINE | ID: mdl-29242172

ABSTRACT

Liver X receptor alpha (LXRα) is a nuclear receptor involved in cholesterol homeostasis. Curcumin, a traditional Chinese derivative from the rhizomes of Curcuma longa and a well-known AMP-activated protein kinase (AMPK) activator, possess hypocholesterolemic activity, however, the possible link between AMPK and cholesterol is unknown. In this study, we have investigated whether curcumin regulates metabolic changes in cholesterol metabolism via LXRα in THP-1 human macrophages, the cells implicated in atheroma plaques formation. Results showed that curcumin induced AMPK phosphorylation, increased LXRα mRNA and protein expression. Curcumin up-regulated mRNA expression of genes involved in cholesterol transport and metabolism as ATP-binding cassette (ABC) transporters ABCA1 and ABCG1, and the sterol response element binding protein 1c (SREBP1c). On the other hand, this increased LXRα mRNA and protein expression was reverted when AMPK was inhibited by its chemical inhibitor, compound C. Transfection with AMPK α1 and α2 siRNA decreased the LXRα mRNA expression and its target genes. Curcumin treatment inhibited cell migration and was also able to promote reverse cholesterol transport in THP-1 cells. This enhanced reverse cholesterol transport might be related to the up-regulating of ABCA1 and ABCG1 mRNA expression by activating AMPK-LXRα signaling in THP-1 cells. This study describes a possible mechanism for understanding the hypocholesterolemic effects of curcumin and expand knowledge about the LXRα regulation by AMPK.


Subject(s)
AMP-Activated Protein Kinases/metabolism , Curcumin/pharmacology , Liver X Receptors/genetics , Macrophages/drug effects , AMP-Activated Protein Kinases/genetics , Biological Transport/drug effects , Cell Movement/drug effects , Cholesterol/metabolism , Gene Expression Regulation/drug effects , Humans , Hydrocarbons, Fluorinated/pharmacology , Liver X Receptors/metabolism , Macrophages/metabolism , Reactive Oxygen Species/metabolism , Sulfonamides/pharmacology , THP-1 Cells
2.
Int Immunopharmacol ; 38: 357-66, 2016 Sep.
Article in English | MEDLINE | ID: mdl-27351826

ABSTRACT

Liver X receptors (LXRs) are ligand-activated nuclear receptors involved mainly in the regulation of cholesterol metabolism in many organs, including liver and intestine, as well as in macrophages and neutrophils. Besides, both anti-inflammatory and pro-inflammatory properties have been ascribed to LXRs. The effect of the inflammatory condition on the expression of LXRα and its target genes has not been previously addressed in human neutrophils. We have described that platelet-activating factor (PAF) and hydrogen peroxide (H2O2) are potent pro-inflammatory mediators that link the haemostatic and innate immune systems. In this work we report that H2O2 at low doses (1 pM-1µM) exerts an inhibitory effect on TO901317-induced mRNA expression of LXRα and of its target genes encoding the ATP-binding cassette (ABC) transporters ABCA1 and ABCG1, and the sterol regulatory element-binding protein 1c (SREBP1c). However, an opposite behaviour, i.e., a transcription-enhancing effect, was found at higher H2O2 doses (100-500µM) on most of these genes. A similar dual effect was observed when the pro-inflammatory molecule PAF was used. Interestingly, H2O2 production separately elicited by 10nM PAF or 1µM H2O2 was similarly low, and analogously, H2O2 production levels elicited by 5µM PAF or 100µM H2O2 were similarly high when they were compared. On the other hand, low doses of PAF or H2O2 induced phosphorylation of extracellular signal-regulated kinases 1 and 2 (ERK 1/2) and NF-κB activation, However, PAF or H2O2 at high doses did not produce changes in NF-κB activation levels. In summary, our results show that H2O2, either exogenous or PAF-induced, exerts a dual regulation on mRNA expression of LXRα and its target genes.


Subject(s)
Carrier Proteins/pharmacology , Hydrogen Peroxide/pharmacology , Liver X Receptors/metabolism , Neutrophils/drug effects , ATP Binding Cassette Transporter 1/genetics , ATP Binding Cassette Transporter 1/metabolism , Cells, Cultured , DNA-Binding Proteins , Extracellular Signal-Regulated MAP Kinases/metabolism , Humans , Hydrocarbons, Fluorinated/pharmacology , Immunity, Innate , Lipid Metabolism , Liver X Receptors/genetics , NF-kappa B/metabolism , Neutrophils/immunology , Phosphorylation/drug effects , Sterol Regulatory Element Binding Protein 1/genetics , Sterol Regulatory Element Binding Protein 1/metabolism , Sulfonamides/pharmacology , Transcriptional Activation/drug effects
3.
FEBS J ; 281(3): 970-82, 2014 Feb.
Article in English | MEDLINE | ID: mdl-24289152

ABSTRACT

Liver X receptors (LXRs) are ligand-activated members of the nuclear receptor superfamily that regulate the expression of genes involved in lipid metabolism and inflammation, although their role in inflammation and immunity is less well known. It has been reported that oxysterols/LXRs may act as anti-inflammatory molecules, although opposite actions have also been reported. In this study, we investigated the effect of platelet-activating factor (PAF), a proinflammatory molecule, on LXRα signalling in human neutrophils. We found that PAF exerted an inhibitory effect on mRNA expression of TO901317-induced LXRα, ATP-binding cassette transporter A1, ATP-binding cassette transporter G1, and sterol response element binding protein 1c. This negative action was mediated by the PAF receptor, and was dependent on the release of reactive oxygen species elicited by PAF, as it was enhanced by pro-oxidant treatment and reversed by antioxidants. Current data also support the idea that PAF induces phosphorylation of the LXRα molecule in an extracellular signal-regulated kinase 1/2-mediated fashion. These results suggest that a possible mechanism by which PAF exerts its proinflammatory effect is through the downregulation of LXRα and its related genes, which supports the notion that LXRα ligands exert a modulatory role in the neutrophil-mediated inflammatory response.


Subject(s)
Down-Regulation , Neutrophils/metabolism , Orphan Nuclear Receptors/metabolism , Platelet Activating Factor/metabolism , Platelet Membrane Glycoproteins/agonists , Receptors, G-Protein-Coupled/agonists , Signal Transduction , ATP Binding Cassette Transporter 1/agonists , ATP Binding Cassette Transporter 1/antagonists & inhibitors , ATP Binding Cassette Transporter 1/genetics , ATP Binding Cassette Transporter 1/metabolism , ATP Binding Cassette Transporter, Subfamily G, Member 1 , ATP-Binding Cassette Transporters/agonists , ATP-Binding Cassette Transporters/antagonists & inhibitors , ATP-Binding Cassette Transporters/genetics , ATP-Binding Cassette Transporters/metabolism , Anticholesteremic Agents/antagonists & inhibitors , Anticholesteremic Agents/pharmacology , Antioxidants/pharmacology , Cells, Cultured , Down-Regulation/drug effects , Humans , Liver X Receptors , Lymphocytes/cytology , Lymphocytes/immunology , Lymphocytes/metabolism , Macrophages/cytology , Macrophages/immunology , Macrophages/metabolism , Neutrophil Activation/drug effects , Neutrophils/cytology , Neutrophils/drug effects , Neutrophils/immunology , Orphan Nuclear Receptors/agonists , Orphan Nuclear Receptors/antagonists & inhibitors , Orphan Nuclear Receptors/genetics , Oxidants/pharmacology , Oxidative Stress/drug effects , Phosphorylation/drug effects , Platelet Activating Factor/agonists , Platelet Activating Factor/antagonists & inhibitors , Platelet Membrane Glycoproteins/antagonists & inhibitors , Platelet Membrane Glycoproteins/metabolism , Protein Isoforms/biosynthesis , Protein Isoforms/genetics , Protein Isoforms/metabolism , Protein Processing, Post-Translational/drug effects , Receptors, G-Protein-Coupled/antagonists & inhibitors , Receptors, G-Protein-Coupled/metabolism , Signal Transduction/drug effects , Sterol Regulatory Element Binding Protein 1/agonists , Sterol Regulatory Element Binding Protein 1/antagonists & inhibitors , Sterol Regulatory Element Binding Protein 1/genetics , Sterol Regulatory Element Binding Protein 1/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...